Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice

Non-small-cell lung cancer (NSCLC) makes up 80–85% of lung cancer diagnoses. Lung cancer patients undergo surgical procedures, chemotherapy, and/or radiation. Chemotherapy and radiation can induce deleterious systemic side effects, particularly within skeletal muscle. To determine whether metformin...

Descripción completa

Detalles Bibliográficos
Autores principales: Stott Bond, Nicole L., Dréau, Didier, Marriott, Ian, Bennett, Jeanette M., Turner, Michael J., Arthur, Susan T., Marino, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615566/
https://www.ncbi.nlm.nih.gov/pubmed/34829914
http://dx.doi.org/10.3390/biomedicines9111685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615566/
https://www.ncbi.nlm.nih.gov/pubmed/34829914
http://dx.doi.org/10.3390/biomedicines9111685

Ejemplares similares